HUP9801386A2 - Szerotonin 5-HT4 receptor parciális agonistáiként és antagonistáiként alkalmazható indazol-karboxamid-származékok, előállításuk és alkalmazásuk, a vegyületeket tartalmazó gyógyászati készítmények - Google Patents

Szerotonin 5-HT4 receptor parciális agonistáiként és antagonistáiként alkalmazható indazol-karboxamid-származékok, előállításuk és alkalmazásuk, a vegyületeket tartalmazó gyógyászati készítmények

Info

Publication number
HUP9801386A2
HUP9801386A2 HU9801386A HUP9801386A HUP9801386A2 HU P9801386 A2 HUP9801386 A2 HU P9801386A2 HU 9801386 A HU9801386 A HU 9801386A HU P9801386 A HUP9801386 A HU P9801386A HU P9801386 A2 HUP9801386 A2 HU P9801386A2
Authority
HU
Hungary
Prior art keywords
compounds
indazolecarboxamide
serotonin
antagonists
receptor
Prior art date
Application number
HU9801386A
Other languages
English (en)
Inventor
John T. Catlow
Marlene L. Cohen
Michael J. Martinelli
John M. Schaus
Steven P. Swanson
Dennis C. Thompson
Thomas M. Wilson
Original Assignee
Eli Lilly And Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/485,956 external-priority patent/US5654320A/en
Application filed by Eli Lilly And Co. filed Critical Eli Lilly And Co.
Publication of HUP9801386A2 publication Critical patent/HUP9801386A2/hu
Publication of HUP9801386A3 publication Critical patent/HUP9801386A3/hu
Publication of HU223973B1 publication Critical patent/HU223973B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

A cím szerinti vegyületek (I) általánős képletében R jelentésehidrőgénatőm, alkil- vagy ciklőalkilcsőpőrt; R1 jelentése hidrőgén-,halőgénatőm, alkil-, hidrőxil-, alkőxi-, alkil-tiő-, cianő-, triflűőr-metil-, karbőxamidő-, mőnő- vagy dialkil-karbőxamidő-csőpőrt; m, n éső jelentése egymástól függetlenül 0, 1, 2, 3, 4 vagy 5, azzal amegkötéssel, hőgy m, n és ő összege 2, 3, 4 vagy 5; R2 jelentésehidrőgénatőm vagy alkilcsőpőrt; R3 és R4 együttes jelentése, azzal anitrőgénatőmmal együtt, amelyhez kapcsőlódnak, 1-pirrőlidinil-, 1-piperazinil-, 1,2,3,4-tetrahidrő-2-izőkinőlinil-, 2,3-dihidrő-1-indőlinil-, 4-mőrfőlinil-, 1-piperidinil- vagy hexametilén-imin-1-il-csőpőrt, amely csőpőrtők bármelyike szűbsztitűált lehet. ŕ
HU9801386A 1995-03-16 1996-03-14 Indazol-karboxamid-származékok, előállításuk és a vegyületeket tartalmazó gyógyászati készítmények HU223973B1 (hu)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40511995A 1995-03-16 1995-03-16
US08/485,956 US5654320A (en) 1995-03-16 1995-06-07 Indazolecarboxamides
PCT/US1996/003551 WO1996033713A1 (en) 1995-03-16 1996-03-14 Indazolecarboxamides

Publications (3)

Publication Number Publication Date
HUP9801386A2 true HUP9801386A2 (hu) 1999-06-28
HUP9801386A3 HUP9801386A3 (en) 2000-03-28
HU223973B1 HU223973B1 (hu) 2005-03-29

Family

ID=27018928

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9801386A HU223973B1 (hu) 1995-03-16 1996-03-14 Indazol-karboxamid-származékok, előállításuk és a vegyületeket tartalmazó gyógyászati készítmények

Country Status (23)

Country Link
US (2) US5798367A (hu)
EP (1) EP0732333B1 (hu)
JP (1) JPH11502230A (hu)
CN (1) CN1112923C (hu)
AT (1) ATE203748T1 (hu)
AU (1) AU700842B2 (hu)
BR (1) BR9608223A (hu)
CA (1) CA2215359A1 (hu)
DE (1) DE69614164T2 (hu)
DK (1) DK0732333T3 (hu)
EA (1) EA000699B1 (hu)
ES (1) ES2159345T3 (hu)
GR (1) GR3037029T3 (hu)
HU (1) HU223973B1 (hu)
IL (1) IL117438A (hu)
NO (1) NO312833B1 (hu)
NZ (1) NZ315971A (hu)
PL (1) PL183867B1 (hu)
PT (1) PT732333E (hu)
RO (1) RO119617B1 (hu)
SK (1) SK283924B6 (hu)
TR (1) TR199700956T1 (hu)
WO (1) WO1996033713A1 (hu)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1291569B1 (it) * 1997-04-15 1999-01-11 Angelini Ricerche Spa Indazolammidi come agenti serotoninergici
US5914405A (en) * 1997-10-07 1999-06-22 Eli Lilly And Company Process for preparing 3-substituted indazoles
US6069152A (en) * 1997-10-07 2000-05-30 Eli Lilly And Company 5-HT4 agonists and antagonists
EE05054B1 (et) * 1998-08-21 2008-08-15 Novartis Ag 5-HT4 agonisti v?i antagonisti peroraalne ravimkoostis ja selle kasutamine meditsiinis
CA2340952C (en) 1998-09-10 2009-12-08 F. Hoffmann-La Roche Ag Dihydrobenzodioxine carboxamide and ketone derivatives as 5-ht4 receptor antagonists
WO2002004411A1 (en) 2000-07-07 2002-01-17 The Administrators Of The Tulane Educational Fund Methods for protection of stratified squamous epithelium against injury by noxious substances and novel agents for use therefor
US20050032866A1 (en) * 2000-08-07 2005-02-10 Bonhomme Mireille Marguerite Jeanne The use of 5ht4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions
EP1321142A1 (en) * 2001-12-21 2003-06-25 Novartis AG Solid pharmaceutical composition for oral administration of Tegaserod
AU2003208711A1 (en) 2002-02-12 2003-09-04 Akzo Nobel N.V. 1-arylsulfonyl-3-substituted indole and indoline derivatives useful in the treatment of central nervous system disorders
ITMI20030287A1 (it) 2003-02-18 2004-08-19 Acraf Indazolammidi dotate di attivita' analgesica metodo, per
ITMI20031467A1 (it) * 2003-07-18 2005-01-19 Acraf Farmaco attivo nel dolore neuropatico
ITMI20031468A1 (it) * 2003-07-18 2005-01-19 Acraf Farmaco ativo nel dolore neuropatico
SE0401969D0 (sv) * 2004-08-02 2004-08-02 Astrazeneca Ab Piperidine derivatives
DE602006010563D1 (de) 2005-07-22 2009-12-31 Pfizer Indazolcarbonsäureamidderivate als agonisten des 5ht4-rezeptors
WO2009106980A2 (en) * 2008-02-29 2009-09-03 Pfizer Inc. Indazole derivatives
GB201511382D0 (en) 2015-06-29 2015-08-12 Imp Innovations Ltd Novel compounds and their use in therapy

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3145215A (en) * 1961-12-19 1964-08-18 Sterling Drug Inc Indazole derivatives
JP2795460B2 (ja) * 1988-06-20 1998-09-10 協和醗酵工業株式会社 ピラゾロアクリドン誘導体
US5017573A (en) * 1988-07-29 1991-05-21 Dainippon Pharmaceutical Co., Ltd. Indazole-3-carboxylic acid derivatives
EP0410509A1 (en) * 1989-07-25 1991-01-30 Duphar International Research B.V New substituted 1H-indazole-3-carboxamides
HU211081B (en) * 1990-12-18 1995-10-30 Sandoz Ag Process for producing indole derivatives as serotonin antagonists and pharmaceutical compositions containing the same
NZ243993A (en) * 1991-08-20 1994-10-26 Smithkline Beecham Plc Pharmaceutical compositions having 5-ht4 receptor antagonist activity and selected compounds having such activity
US5552398A (en) * 1991-09-12 1996-09-03 Smithkline Beecham P.L.C. Azabicyclic compounds as 5-HT4 receptor antagonists
AU4081393A (en) * 1992-05-23 1993-12-30 Smithkline Beecham Plc Medicaments for the treatment of anxiety
WO1994000113A2 (en) * 1992-06-27 1994-01-06 Smithkline Beecham Plc Medicaments containing 5-ht4 receptor antagonists
MX9305947A (es) * 1992-09-29 1994-06-30 Smithkline Beecham Plc Compuestos antagonistas del receptor 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
TW251287B (hu) * 1993-04-30 1995-07-11 Nissei Co Ltd
GB9310582D0 (en) * 1993-05-22 1993-07-07 Smithkline Beecham Plc Pharmaceuticals

Also Published As

Publication number Publication date
PL183867B1 (pl) 2002-07-31
GR3037029T3 (en) 2002-01-31
NZ315971A (en) 1999-01-28
EP0732333A1 (en) 1996-09-18
NO974221D0 (no) 1997-09-12
CN1112923C (zh) 2003-07-02
IL117438A0 (en) 1996-07-23
EP0732333B1 (en) 2001-08-01
ATE203748T1 (de) 2001-08-15
HUP9801386A3 (en) 2000-03-28
DK0732333T3 (da) 2001-10-08
RO119617B1 (ro) 2005-01-28
AU700842B2 (en) 1999-01-14
HU223973B1 (hu) 2005-03-29
TR199700956T1 (xx) 1998-02-21
US5817676A (en) 1998-10-06
DE69614164D1 (de) 2001-09-06
EA000699B1 (ru) 2000-02-28
MX9706967A (es) 1997-11-29
IL117438A (en) 2001-12-23
PT732333E (pt) 2001-11-30
DE69614164T2 (de) 2002-04-25
EA199700242A1 (ru) 1998-04-30
SK283924B6 (sk) 2004-05-04
NO312833B1 (no) 2002-07-08
CN1183041A (zh) 1998-05-27
NO974221L (no) 1997-10-27
BR9608223A (pt) 1998-12-29
CA2215359A1 (en) 1996-10-31
AU6894896A (en) 1996-11-18
ES2159345T3 (es) 2001-10-01
US5798367A (en) 1998-08-25
SK124297A3 (en) 1998-02-04
PL322362A1 (en) 1998-01-19
WO1996033713A1 (en) 1996-10-31
JPH11502230A (ja) 1999-02-23

Similar Documents

Publication Publication Date Title
HUP9801386A2 (hu) Szerotonin 5-HT4 receptor parciális agonistáiként és antagonistáiként alkalmazható indazol-karboxamid-származékok, előállításuk és alkalmazásuk, a vegyületeket tartalmazó gyógyászati készítmények
HUP9801900A2 (hu) 2-Metoxi-benzofenon-származékok, intermedierjeik, előállításuk és alkalmazásuk, hatóanyagként ezeket a vegyületeket tartalmazó fungicid készítmények
HUP0001192A2 (hu) Topiramát és származékainak alkalmazása elhízás kezelésére használható gyógyszerkészítmények előállítására
SE8200916L (sv) Karbostyrilderivat, forfarande for framstellning derav och hjertsterkande komposition som innehaller detsamma
AR035153A1 (es) Derivados de carboxamidas y cetonas de dihidrobenzodioxina
KR910016697A (ko) 테트라히드로피리딘 유도체
ES2174298T3 (es) Derivados de aminotiazol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
OA08635A (fr) Dérivés de la benzhydryloxyéthyl-pipérazine, procédés d'obtention et de compositions pharmaceutiques les contenant.
ES2162404T3 (es) Nuevos derivados del indol y del indazol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
SE7501365L (hu)
KR920016448A (ko) 피페리딘 유도체
HUP0104852A2 (hu) Oktahidro-pirido-pirazil-származékok és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
AU643290B2 (en) Derivatives of 2-aminoalkyl-5-arylalkyl-1,3-dioxanes, their preparation and their therapeutic application
ATE102199T1 (de) 4-amino-3-carboxynaphthyridin-derivate, ihre herstellung und pharmazeutische zusammensetzungen.
ATE170851T1 (de) Guanidinothiazolederivate und ihre anwendung als h2-rezeptor-antagonisten
YU78100A (sh) 4,5,6 i 7-indol i indolin derivati, njihova izrada i upotreba
HUP0000275A2 (hu) Fenantridiniumszármazékok, valamint ezeket a vegyületeket tartalmazó gyógyászati készítmények
DK0765322T3 (da) Indolderivater som pro-drugs for 5-HT1-lignende receptoragonister
IL83216A (en) 1((5-(10->9)abeo-6-methylergolin-8beta-yl)methyl)-imidazolidine-(and hexahydropyrimidine)-2,4-dione derivatives,their preparation and pharmaceutical compositions containing them
DE3166645D1 (en) Dibenzoxazonine, dibenzoxazecine, dibenzoxaazacycloundecane derivatives and their corresponding thia- and aza derivatives, their preparation and pharmaceutical compositions

Legal Events

Date Code Title Description
HFG4 Patent granted, date of granting

Effective date: 20050217

MM4A Lapse of definitive patent protection due to non-payment of fees